Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.
Marco RavanelliGiorgio Maria AgazziElena TononcelliElisa RocaPaolo CabassaGianluca BaiocchiAlfredo BerrutiRoberto MaroldiDavide FarinaPublished in: La Radiologia medica (2019)
Texture analysis on contrast-enhanced CT stratified response probability and prognosis in patients with colorectal liver metastases treated with bevacizumab-containing therapy. This result was specific for the bevacizumab group.
Keyphrases
- contrast enhanced
- liver metastases
- diffusion weighted
- magnetic resonance imaging
- magnetic resonance
- computed tomography
- metastatic colorectal cancer
- diffusion weighted imaging
- dual energy
- locally advanced
- stem cells
- image quality
- squamous cell carcinoma
- chemotherapy induced
- rectal cancer
- newly diagnosed
- replacement therapy